HOUSTON and BOSTON, JANUARY 7, 2026 ― The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics ...
A clinically validated screening tool, now redesigned for parents with AI support and instant results at home. ATLANTA, Aug. 25, 2025 /PRNewswire/ -- Neo Sophia today announced the launch of Screener, ...
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine To advance the adoption of precision oncology, it is crucial to have access to ...
BOSTON and HOUSTON, Jan. 7, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results